Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche

Lichen planopilaris (LPP) is a chronic inflammatory disease of unknown pathogenesis that leads to permanent hair loss. Whilst destruction of epithelial hair follicle stem cells (eHFSCs) that reside in an immunologically protected niche of the HF epithelium, the bulge, is a likely key event in LPP pathogenesis, this remains to be demonstrated. We have tested the hypotheses that bulge immune privilege (IP) collapse and inflammation‐induced eHFSC death are key components in the pathogenesis of LPP. Biopsies of lesional and non‐lesional scalp skin from adult LPP patients (n = 42) were analysed by quantitative (immuno)histomorphometry, real‐time quantitative polymerase chain reaction (qRT–PCR), laser capture microdissection and microarray analysis, or skin organ culture. At both the protein and transcriptional level, lesional LPP HFs showed evidence for bulge IP collapse (ie increased expression of MHC class I and II, β2microglobulin; reduced TGFβ2 and CD200 expression). This was accompanied by a Th1‐biased cytotoxic T cell response (ie increased CD8+ GranzymeB+ T cells and CD123+ plasmacytoid dendritic cells, with increased CXCR3 expression) and increased expression of interferon‐inducible chemokines (CXCL9/10/11). Interestingly, lesional LPP eHFSCs showed both increased proliferation and apoptosis in situ. Microarray analysis revealed a loss of eHFSC signatures and increased expression of T cell activation/binding markers in active LPP, while bulge PPARγ transcription was unaltered compared to non‐lesional LPP HFs. In organ culture of non‐lesional LPP skin, interferon‐γ (IFNγ) induced bulge IP collapse. LPP is an excellent model disease for studying and preventing immune destruction of human epithelial stem cells in situ. These novel findings raise the possibility that LPP represents an autoimmune disease in whose pathogenesis IFNγ‐induced bulge IP collapse plays an important role. Therapeutically, bulge IP protection/restoration may help to better manage this highly treatment‐resistant cicatricial alopecia. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  J. Shapiro,et al.  Somatostatin expression in human hair follicles and its potential role in immune privilege. , 2013, The Journal of investigative dermatology.

[2]  Y. Tokura,et al.  CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase. , 2013, Journal of dermatological science.

[3]  Liang-Tung Yang,et al.  Differential response of epithelial stem cell populations in hair follicles to TGF-β signaling. , 2013, Developmental biology.

[4]  C. Craddock,et al.  Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD. , 2012, Blood.

[5]  K. Nylander,et al.  Increased levels of COX‐2 in oral lichen planus supports an autoimmune cause of the disease , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  R. Paus,et al.  Primary cicatricial alopecias: a U.K. survey , 2012, The British journal of dermatology.

[7]  K. Horiuchi,et al.  Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin , 2012, Nature Immunology.

[8]  J. Dutz,et al.  Type 1 IFN‐induced protein MxA and plasmacytoid dendritic cells in lesions of morphea , 2012, Experimental dermatology.

[9]  A. Tosti,et al.  Treatment options for alopecia: an update, looking to the future , 2012, Expert opinion on pharmacotherapy.

[10]  A. Baibergenova,et al.  Use of Pioglitazone in Patients with Lichen Planopilaris , 2012, Journal of cutaneous medicine and surgery.

[11]  Mayumi Ito,et al.  Dissecting the bulge in hair regeneration. , 2012, The Journal of clinical investigation.

[12]  J. Sundberg,et al.  Increased expression of Cxcr3 and its ligands, Cxcl9, and Cxcl10, during the development of alopecia areata in the mouse , 2012, The Journal of investigative dermatology.

[13]  E. Fuchs,et al.  Paracrine TGF-β signaling counterbalances BMP-mediated repression in hair follicle stem cell activation. , 2012, Cell stem cell.

[14]  M. Ohyama Primary cicatricial alopecia: Recent advances in understanding and management , 2012, The Journal of dermatology.

[15]  W. Bergfeld,et al.  Differential expression of stem cell markers in lichen planopilaris and alopecia areata , 2011, The British journal of dermatology.

[16]  C. Ko,et al.  Hypertrophic lupus erythematosus: the diagnostic utility of CD123 staining , 2011, Journal of cutaneous pathology.

[17]  M. Rotondi,et al.  The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. , 2011, Current pharmaceutical design.

[18]  R. Tirumalae,et al.  Histopathology of Scarring Alopecia in Indian Patients , 2011, The American Journal of dermatopathology.

[19]  R. Paus,et al.  Can the hair follicle become a model for studying selected aspects of human ocular immune privilege? , 2011, Investigative ophthalmology & visual science.

[20]  Charles P. Lin,et al.  In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche , 2011, Nature.

[21]  K. Ranganathan,et al.  Oral lichen planus: An update on pathogenesis and treatment , 2011, Journal of oral and maxillofacial pathology : JOMFP.

[22]  B. Smoller,et al.  Comparison Between Langerhans Cell Concentration in Lichen Planopilaris and Traction Alopecia With Possible Immunologic Implications , 2011, The American Journal of dermatopathology.

[23]  F. Watt,et al.  The Basement Membrane of Hair Follicle Stem Cells Is a Muscle Cell Niche , 2011, Cell.

[24]  J. Tobias,et al.  Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells. , 2011, The Journal of clinical investigation.

[25]  J. Shapiro,et al.  Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. , 2010, The Journal of investigative dermatology.

[26]  R. Paus,et al.  The pathogenesis of primary cicatricial alopecias. , 2010, The American journal of pathology.

[27]  H. Waldmann Tolerance: an overview and perspectives , 2010, Nature Reviews Nephrology.

[28]  R. Paus,et al.  IFN-gamma induces bulge immunoprivilege collapse and may cause epithelial stem cell exhaust , 2010 .

[29]  R. Paus,et al.  Management of alopecia areata , 2010, BMJ : British Medical Journal.

[30]  K. Stenn,et al.  Lipids to the top of hair biology. , 2010, The Journal of investigative dermatology.

[31]  C. Blanpain,et al.  A dominant role of the hair follicle stem cell niche in regulating melanocyte stemness. , 2010, Cell stem cell.

[32]  Mohamed El-behi,et al.  Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis , 2010, Journal of Neuroimmune Pharmacology.

[33]  K. Meyer,et al.  Does collapse of immune privilege in the hair‐follicle bulge play a role in the pathogenesis of primary cicatricial alopecia? , 2009, Clinical and experimental dermatology.

[34]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.

[35]  R. Paus,et al.  Nonviral In Situ Green Fluorescent Protein Labeling and Culture of Primary, Adult Human Hair Follicle Epithelial Progenitor Cells , 2009, Stem cells.

[36]  E. Ingham,et al.  Expression of hair follicle stem cells detected by cytokeratin 15 stain: implications for pathogenesis of the scarring process in cutaneous lupus erythematosus , 2009, The British journal of dermatology.

[37]  Kevin D Cooper,et al.  Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. , 2009, The Journal of investigative dermatology.

[38]  Ralf Paus,et al.  Scarring alopecia and the PPAR-gamma connection. , 2009, The Journal of investigative dermatology.

[39]  A. Tosti,et al.  How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia , 2009, The British journal of dermatology.

[40]  P. Assouly,et al.  Lichen planopilaris: update on diagnosis and treatment. , 2009, Seminars in cutaneous medicine and surgery.

[41]  A. Munnich,et al.  Stabilization of RNA during laser capture microdissection by performing experiments under argon atmosphere or using ethanol as a solvent in staining solutions. , 2008, RNA.

[42]  F. Wojnarowska,et al.  The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. , 2008, Archives of dermatology.

[43]  R. Paus,et al.  Evidence that the bulge region is a site of relative immune privilege in human hair follicles , 2008, The British journal of dermatology.

[44]  J. Wenzel,et al.  An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". , 2008, The Journal of investigative dermatology.

[45]  M. Mahalingam,et al.  Involvement of the bulge region in primary scarring alopecia , 2008, Journal of cutaneous pathology.

[46]  R. Paus,et al.  Management of primary cicatricial alopecias: options for treatment , 2008, The British journal of dermatology.

[47]  R. Paus,et al.  Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche , 2008, Experimental dermatology.

[48]  R. Paus,et al.  Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. , 2008, The Journal of investigative dermatology.

[49]  E. Fuchs,et al.  NFATc1 Balances Quiescence and Proliferation of Skin Stem Cells , 2008, Cell.

[50]  T. Bieber,et al.  CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. , 2007, Journal of the American Academy of Dermatology.

[51]  R. Paus,et al.  Towards the development of a simplified long‐term organ culture method for human scalp skin and its appendages under serum‐free conditions , 2007, Experimental dermatology.

[52]  S. Wahl,et al.  TGF‐β: a mobile purveyor of immune privilege , 2006 .

[53]  G. Cotsarelis Epithelial stem cells: a folliculocentric view. , 2006, The Journal of investigative dermatology.

[54]  J. Niederkorn See no evil, hear no evil, do no evil: the lessons of immune privilege , 2006, Nature Immunology.

[55]  M. Rosenblum,et al.  CD200, a "no danger" signal for hair follicles. , 2006, Journal of dermatological science.

[56]  G. Cotsarelis Gene expression profiling gets to the root of human hair follicle stem cells. , 2005, The Journal of clinical investigation.

[57]  Mark C Udey,et al.  Characterization and isolation of stem cell-enriched human hair follicle bulge cells. , 2005, The Journal of clinical investigation.

[58]  Jane Q. Nguyen,et al.  Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis , 2005, Nature Medicine.

[59]  H. Kamino,et al.  Possible role of the bulge region in the pathogenesis of inflammatory scarring alopecia: lichen planopilaris as the prototype , 2005, Journal of cutaneous pathology.

[60]  E. Poblet,et al.  Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study , 2005, International journal of dermatology.

[61]  J. Shapiro,et al.  Update on primary cicatricial alopecias. , 2005, Journal of the American Academy of Dermatology.

[62]  P. Arck,et al.  Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. , 2004, The Journal of investigative dermatology.

[63]  Yaping Liu,et al.  Capturing and profiling adult hair follicle stem cells , 2004, Nature Biotechnology.

[64]  R. Paus,et al.  Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. , 2004, The American journal of pathology.

[65]  E. Fuchs,et al.  Defining the Epithelial Stem Cell Niche in Skin , 2004, Science.

[66]  P. Sugerman,et al.  The pathogenesis of oral lichen planus. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[67]  S. Millar,et al.  Towards a molecular understanding of hair loss and its treatment. , 2001, Trends in molecular medicine.

[68]  D. Tobin,et al.  Patterns of proliferation and apoptosis during murine hair follicle morphogenesis. , 2001, The Journal of investigative dermatology.

[69]  D. Tobin,et al.  The human hair follicle immune system: cellular composition and immune privilege , 2000, The British journal of dermatology.

[70]  R. Paus,et al.  MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. , 1998, The Journal of investigative dermatology.

[71]  S. Gibbs,et al.  Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. , 2012, The Journal of investigative dermatology.

[72]  T. Bieber,et al.  Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosus. , 2011, The Journal of investigative dermatology.

[73]  Robert H. Bell,et al.  Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray. , 2010, Journal of dermatological science.

[74]  T. Bieber,et al.  Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus , 2008, Archives of Dermatological Research.

[75]  A. Bosio,et al.  Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. , 2008, The Journal of investigative dermatology.

[76]  T. Shiohara,et al.  Pathomechanisms of lichen planus autoimmunity elicited by cross-reactive T cells. , 2008, Current directions in autoimmunity.

[77]  R. Paus,et al.  A 'hairy' privilege. , 2005, Trends in immunology.

[78]  J. M. Weitzner Alopecia areata. , 1990, American family physician.